OncoCyte Corporation (OCX)
NASDAQ: OCX · Real-Time Price · USD
2.670
-0.080 (-2.89%)
Nov 21, 2024, 2:43 PM EST - Market open

OncoCyte Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
452138200161117
Upgrade
Market Cap Growth
48.24%-45.76%-80.98%24.52%37.45%108.38%
Upgrade
Enterprise Value
47141416215998
Upgrade
Last Close Price
2.752.506.4243.4047.8045.00
Upgrade
PS Ratio
41.8313.7439.7491.06132.18-
Upgrade
PB Ratio
3.790.810.963.074.803.79
Upgrade
P/TBV Ratio
----17.313.79
Upgrade
EV/Sales Ratio
66.189.6015.0773.75130.37-
Upgrade
Debt / Equity Ratio
0.410.110.090.090.260.19
Upgrade
Asset Turnover
0.010.020.010.020.03-
Upgrade
Quick Ratio
0.391.381.852.500.895.06
Upgrade
Current Ratio
0.531.492.112.771.035.17
Upgrade
Return on Equity (ROE)
-165.32%-76.26%-35.52%-88.37%-93.07%-130.91%
Upgrade
Return on Assets (ROA)
-18.84%-15.91%-13.88%-13.82%-42.66%-56.30%
Upgrade
Return on Capital (ROIC)
-48.27%-38.88%-31.60%-26.30%-51.52%-66.32%
Upgrade
Earnings Yield
-95.94%-134.52%-191.48%-32.03%-18.62%-19.18%
Upgrade
FCF Yield
-48.09%-114.30%-131.09%-19.08%-16.93%-17.64%
Upgrade
Buyback Yield / Dilution
-52.77%-38.10%-24.61%-35.80%-27.65%-35.52%
Upgrade
Total Shareholder Return
-52.77%-38.10%-24.61%-35.80%-27.65%-35.52%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.